Quick Answer
OS Therapies Inc reported Operating Income of -$28.71 million for fiscal year 2025.
OS Therapies Inc Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$28.71M | -321.3% |
| 2024 | -$6.81M | -56.9% |
| 2023 | -$4.34M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.88M | -182.3% | -42.2% |
| June 30, 2025 | -$4.84M | -520.5% | +3.2% |
| March 31, 2025 | -$5.00M | -693.3% | -105.1% |
| September 30, 2024 | -$2.44M | -291.7% | -212.6% |
| June 30, 2024 | -$779.8K | +48.5% | -23.7% |
| March 31, 2024 | -$630.2K | +39.9% | -1.3% |
| September 30, 2023 | -$622.2K | — | +58.9% |
| June 30, 2023 | -$1.52M | — | -44.6% |
- OS Therapies Inc showed a decrease of -321.3% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, OS Therapies Inc’s operating income has declined by 561.0% (from -$4.34 million to -$28.71 million).
- The most recent figure is from OS Therapies Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: